UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Antimullerian Hormone Levels in Girls and Adolescents Receiving Gonadotoxic Cancer Therapies
    Barbara Stegmann
  2. A multicenter, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with 177Lu-DOTA0-Tyr3-Octreotate to...
    David Bushnell
  3. Medamacs: The Medical Arm of Mechanical Circulatory Support
    Linda Cadaret
  4. A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus
    David Bender
  5. Transfusion of Prematures (TOP) Trial
    Edward F. Bell
  6. A Phase II Evaluation of SU11248 (Sunitinib Malate) (IND #74019, NSC #736511) in the Treatment of Persistent or Recurrent Clear Cell Ovarian Carcinoma
    David Bender
  7. A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexat…
    Ayman El-Sheikh
  8. Cognitive and Psychiatric Functioning in Adults with Carcinoid Tumors
    Susan Schultz
  9. Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for castration resistant metastatic prostate cancer
    Daniel Vaena
  10. Randomized Phase II Study Comparing the MET inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma
    Mohammed Milhem
  11. Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc P(1)
    Brian Link
  12. GOG 3001/ Amgen TRINOVA-3 - A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III…
    David Bender
  13. Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab...
    Ayman El-Sheikh
  14. A Phase III Randomized Trial of Gemcitabine (NSC# 613327) plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) vs. Observation for Uterus-limited, High Grade Uterine Leiomyosarcoma
    David Bender
  15. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Lenalidomide...
    Brian Link
  16. A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton
    Brian Link
  17. A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab...
    Mohammed Milhem
  18. Randomized, double-blind phase III study of Pazopanib vs Placebo in subjects with metastatic renal cell carcinoma who have no evidence of disease...
    Daniel Vaena
  19. A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma(1)
    Mohammed Milhem
  20. Biobehavioral-Cytokine Interactions in Ovarian Cancer
    Susan Lutgendorf

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.